Works matching DE "GENERIC drug laws"

Results: 163

Patent Thickets and Product Hops: Challenges and Opportunities for Legislative Reform.

Published in:

Journal of Law, Medicine & Ethics, 2025, v. 53, n. 1, p. 158, doi. 10.1017/jme.2025.54

By:

Feldman, William B.

Publication type:

Article

This Week's Advocacy News: 'Wyden and Crapo Release Draft Legislation to Combat Prescription Drug Shortages'.

Published in:

ONS Voice, 2024, p. 1

By:

Vickery, Jaimie

Publication type:

Article

Reverse Payment Settlements: How Actavis Activated the Rule of Reason.

Published in:

Journal of Corporation Law, 2014, v. 39, n. 4, p. 859

By:

Estwick, Christopher O.

Publication type:

Article

Generic Drug Manufacturer Liability: Achieving a Balance Between Consumer Affordability and Safety.

Published in:

Journal of Corporation Law, 2012, v. 38, n. 1, p. 177

By:

James, Sarah S.

Publication type:

Article

Too Good To Last? Will the FDA'S Proposed Rule Put an End to Generic Drug Preemption Under Mensing and Bartlett?

Published in:

Defense Counsel Journal, 2015, v. 82, n. 1, p. 28, doi. 10.12690/IADC-15-002

By:

Diab, Tony M.

Publication type:

Article

China.

Published in:: Journal of Global Health, 2012, v. 2, n. 2, p. 2, doi. 10.7189/jogh.02.020201
Publication type:: Article

REVERSE PAYMENTS IN THE PHARMACEUTICAL INDUSTRY: FINDING THE RIGHT PRESCRIPTION.

Published in:

Southern Law Journal, 2012, v. 22, n. 1, p. 61

By:

Royalty, Kent W;
Oliva, Suzanne;
Fix, William A.

Publication type:

Article

ALLOWING ACCESS TO JUSTICE FOR GENERIC DRUG USERS? A GOOD FAITH ARGUMENT FOR HOLDING THAT BRAND-NAME MANUFACTURERS ARE SUBJECT TO REPRESENTATIONS MADE ON GENERIC DRUG LABELS.

Published in:

Journal of the Legal Profession, 2015, v. 40, n. 1, p. 131

By:

Stallings, Michael

Publication type:

Article

Adverse Reaction Without a Remedy.

Published in:

Alabama Lawyer, 2012, v. 73, n. 1, p. 59

By:

Casey, Steven F.;
Lester, David A.

Publication type:

Article

In re K-Dur Antitrust Litigation--Reverse Payments : Against Prices, Purchasers, and Policy.

Published in:

Tulane Journal of Technology & Intellectual Property, 2012, v. 15, p. 293

By:

Bateman, Meredith

Publication type:

Article

Made in India: The Label on your Prescription Refill.

Published in:

Transnational Law & Contemporary Problems, 2016, v. 25, n. 2, p. 393

By:

Rawal, Malvika

Publication type:

Article

A HARD PILL TO SWALLOW: SYMPTOMS AND PROGNOSIS OF THE DRUG MANUFACTURER PREEMPTION DEFENSE IN 2018.

Published in:

Touro Law Review, 2018, v. 34, n. 2, p. 689

By:

Stephens, Brandon

Publication type:

Article

Bill to help Canadian companies ship generics has uncertain future.

Published in:

Nature Medicine, 2011, v. 17, n. 3, p. 234, doi. 10.1038/nm0311-234b

By:

Hoag, Hannah

Publication type:

Article

'Pay-for-delay' decision may be left to lawmakers.

Published in:

Nature Medicine, 2010, v. 16, n. 10, p. 1052, doi. 10.1038/nm1010-1052b

By:

Hutson, Stu

Publication type:

Article

Courts address venue for cases brought under the Hatch-Waxman Act.

Published in:

Journal of Generic Medicines, 2021, v. 17, n. 1, p. 29, doi. 10.1177/1741134321992396

By:

Hamidinia, Shawn;
Braier, Paul A.

Publication type:

Article

Carved out indications and patents in Australia: The story continues.

Published in:

Journal of Generic Medicines, 2014, v. 11, n. 1/2, p. 90, doi. 10.1177/1741134314553141

By:

Condon, Wayne

Publication type:

Article

On litigating Hatch-Waxman Patent infringement cases in the Eastern District of Virginia.

Published in:

Journal of Generic Medicines, 2014, v. 11, n. 1/2, p. 73, doi. 10.1177/1741134314553225

By:

Pejic, P. Branko

Publication type:

Article

Usage of generics in Ireland: Recent trends and policy developments.

Published in:

Journal of Generic Medicines, 2013, v. 10, n. 2, p. 72, doi. 10.1177/1741134313515667

By:

Brick, Aoife;
Gorecki, Paul K;
Nolan, Anne

Publication type:

Article

How safe is the safe harbor provision of the Hatch-Waxman Act, 35 U.S.C. §271(e)(1)?

Published in:

Journal of Generic Medicines, 2013, v. 10, n. 2, p. 122, doi. 10.1177/1741134313494082

By:

Hollander, Barry I

Publication type:

Article

The role of the product label in patent infringement.

Published in:

Journal of Generic Medicines, 2012, v. 9, n. 3, p. 144, doi. 10.1177/1741134312456693

By:

Braier, Paul A

Publication type:

Article

Pharmaceutical; Trademark; Patents; News.

Published in:

Journal of Generic Medicines, 2012, v. 9, n. 2, p. 95, doi. 10.1177/1741134312445868

By:

Milchior, Richard;
Charbonnel, Séverine

Publication type:

Article

The America Invents Act: Post-grant review and paragraph IV certifications.

Published in:

Journal of Generic Medicines, 2012, v. 9, n. 1, p. 5, doi. 10.1177/1741134311435766

By:

Rein, Frederick H;
Crystal, Joseph B

Publication type:

Article

Generic Medicines: the key to a sustainable health care system.

Published in:: 2011
Publication type:: Editorial

Alleged infringers are likely to have a tougher time proving inequitable conduct.

Published in:

Journal of Generic Medicines, 2011, v. 8, n. 3, p. 172, doi. 10.1177/1741134311422985

By:

Angres, Mark B;
Braier, Paul A

Publication type:

Article

Citizen petitions: barriers to entry for generic medicines? An update and evaluation of petitions, their management, and disposition from 2004 to 2010.

Published in:

Journal of Generic Medicines, 2011, v. 8, n. 3, p. 166, doi. 10.1177/1741134311420330

By:

Glass, Gregory;
Collins, Erin

Publication type:

Article

The reality behind the rhetoric: How European policies risk harming access to generic medicines in developing countries.

Published in:

Journal of Generic Medicines, 2011, v. 8, n. 1, p. 14, doi. 10.1057/jgm.2011.1

By:

Arkinstall, James;
Childs, Michelle;
Menghaney, Leena;
Ford, Nathan;
von Schoen-Angerer, Tido

Publication type:

Article

European case law report.

Published in:

Journal of Generic Medicines, 2010, v. 7, n. 3, p. 281, doi. 10.1057/jgm.2010.20

By:

Burdon, Michael;
Singleton, Rebecca;
Katzka, Catherine

Publication type:

Article

Governments have begun to act but more needs to be done to stop patent lawsuit abuse.

Published in:

Journal of Generic Medicines, 2010, v. 7, n. 3, p. 215, doi. 10.1057/jgm.2010.22

By:

Jorge, Maria Fabiana

Publication type:

Article

Assessment of generic drug discount programs offered by large chain pharmacies in the United States.

Published in:

Journal of Generic Medicines, 2009, v. 6, n. 4, p. 363, doi. 10.1057/jgm.2009.24

By:

Dwibedi, Nilanjana;
Sansgiry, Sujit S.

Publication type:

Article

The Brazilian generic market.

Published in:

Journal of Generic Medicines, 2009, v. 6, n. 4, p. 345, doi. 10.1057/jgm.2009.25

By:

Piochi Lobo, Luciano M.

Publication type:

Article

Indirect patent infringement in the US: Points to consider for generic and API manufacturers.

Published in:

Journal of Generic Medicines, 2007, v. 4, n. 4, p. 287, doi. 10.1057/palgrave.jgm.4950080

By:

Braier, Paul A;
Jayaprakash, Azza M

Publication type:

Article

Mylan v FDA: Another court decision in favour of ‘authorised generics’.

Published in:

Journal of Generic Medicines, 2006, v. 4, n. 1, p. 46, doi. 10.1057/palgrave.jgm.4950043

By:

Rein, Frederick H;
Kessel, Amanda M

Publication type:

Article

Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018.

Published in:

JAMA Network Open, 2020, v. 3, n. 8, p. e2013595, doi. 10.1001/jamanetworkopen.2020.13595

By:

Alpern, Jonathan D.;
Shahriar, Arman A.;
Xi, Min;
Thapa, Sunita;
Kodet, Amy J.;
Stauffer, William M.;
Vazquez Benitez, Gabriela;
Pawloski, Pamala A.;
Dehmer, Steven P.

Publication type:

Article

India's trade-related aspects of Intellectual Property Rights compliant pharmaceutical patent laws: what lessons for India and other developing countries?

Published in:

Information & Communications Technology Law, 2014, v. 23, n. 1, p. 1, doi. 10.1080/13600834.2014.891310

By:

Sundaram, Jae

Publication type:

Article

BIOLOGICS IN THE PRACTICE OF LAW.

Published in:

2016

By:

KELLY, LINDSAY

Publication type:

Essay

Generic Drug Inflation Fallout: Rising Tide of Social Media Influence and Penalties.

Published in:

Journal of Health Care Compliance, 2016, v. 18, n. 2, p. 21

By:

Blank, Robert

Publication type:

Article

Don't sacrifice generic drug industry for sake of Canada-European trade deal.

Published in:

Canadian Pharmacists Journal, 2013, v. 146, n. 1, p. 16, doi. 10.1177/1715163512473930

By:

Lynas, Kathie

Publication type:

Article

Supreme Court of Canada to Hear Pharmacy Challenges to Ontario Ban on Private-Label Generics.

Published in:: Canadian Pharmacists Journal, 2012, v. 145, n. 6, p. 247, doi. 10.3821/145.6.cpj247
Publication type:: Article

PEI moves to lower generic drug prices.

Published in:

Canadian Pharmacists Journal, 2012, v. 145, n. 4, p. 160, doi. 10.3821/1913-701X-145.4.160b

By:

Lynas, Kathie

Publication type:

Article

BC government introduces generic pricing legislation but uncertainty remains for pharmacy.

Published in:

Canadian Pharmacists Journal, 2012, v. 145, n. 4, p. 157, doi. 10.3821/145.4.cpj157

By:

Lynas, Kathie

Publication type:

Article

Canada's generic drug sector could face more change from Ontario court ruling and possible Canada-EU trade deal.

Published in:

Canadian Pharmacists Journal, 2011, v. 144, n. 2, p. 52, doi. 10.3821/1913-701X-144.2.52

By:

Lynas, Kathie

Publication type:

Article

A licence to lower costs.

Published in:: Chemistry & Industry, 2012, v. 76, n. 10, p. 45, doi. 10.1002/cind.7610_15.x
Publication type:: Article

Patent battle decisive.

Published in:: 2012
Publication type:: Opinion

Rulings mean phama companies face tougher markets in the US.

Published in:: Chemistry & Industry, 2003, n. 6, p. 4
Publication type:: Article

When Do Generics Challenge Drug Patents?

Published in:

Journal of Empirical Legal Studies, 2011, v. 8, n. 4, p. 613, doi. 10.1111/j.1740-1461.2011.01235.x

By:

Hemphill, C. Scott;
Sampat, Bhaven N.

Publication type:

Article

EXCESSIVE PRICING OF OFF-PATENT PHARMACEUTICALS: HATCH IT OR RATCHET?

Published in:

New York University Law Review, 2017, v. 92, n. 4, p. 1146

By:

GRABER, JENNIFER L.

Publication type:

Article

REFORMING JUDICIAL REVIEW OF BIOEQUIVALENCE DETERMINATIONS.

Published in:

New York University Law Review, 2012, v. 87, n. 6, p. 2040

By:

KOCHEVAR, CHRISTOPHER J.

Publication type:

Article

National Medical Commission’s Generic Drug Policy: A Boon or a Bane for RMPs and Public Health?

Published in:

Journal of Medical Evidence, 2024, v. 5, n. 1, p. 82, doi. 10.4103/JME.JME_154_23

By:

Singhal, Arjun Kumar;
Siddiqui, Merajul Haque;
Goldar, Shalini;
Kumar, Naveen;
Agrawal, Sonu Kumari

Publication type:

Article

Medicamentos genricos no Brasil: panorama hist¢rico e legislaÆo.

Published in:

Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2010, v. 28, n. 6, p. 480, doi. 10.1590/S1020-49892010001200010

By:

Ara£jo, Lorena Ulha;
Albuquerque, Kemile Toledo de;
Kato, Kelly Cristina;
Silveira, Gleiciely Santos;
Maciel, Nira Rezende;
Sp¢sito, Pollyanna μlvaro;
Barcellos, Neila Mrcia Silva;
Souza, Jacqueline de;
Bueno, Mrcia;
Storpirtis, Sílvia

Publication type:

Article

The Politics and Policies of Regulating Generics in Latin America: A Survey of Seventeen States.

Published in:

Journal of Health Politics, Policy & Law, 2017, v. 42, n. 3, p. 485, doi. 10.1215/03616878-3802953

By:

Sweet, Cassandra M.

Publication type:

Article